Chemotherapy

In this Thursday, May 24, 2018 photo, Adine Usher, 78, meets with breast cancer study leader Dr. Joseph Sparano at the Montefiore and Albert Einstein College of Medicine in the Bronx borough of New York. Usher was one of about 10,000 participants in the study which shows women at low or intermediate risk for breast cancer recurrence may safely skip chemotherapy without hurting their chances of survival. (AP Photo/Kathy Young)
June 04, 2018 - 1:17 am
CHICAGO (AP) — Most women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease, doctors are reporting from a landmark study that used genetic testing to gauge each patient's risk. The study is the largest ever done...
Read More
This 2015 photo made available by Merck shows the drug Keytruda. Research released on Monday, April 16, 2018 suggests that many more lung cancer patients may benefit from treatments that boost the immune system, which have scored some of their biggest wins until now in less common cancer types. Using one of these drugs _ Merck's Keytruda _ with usual chemotherapy extended survival for people newly diagnosed with the most common type of cancer that had spread beyond the lungs, one study found. (Michael Lund/Merck via AP)
April 16, 2018 - 10:42 am
CHICAGO (AP) — For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It's the biggest win so far for immunotherapy, which has had much of its success until now in less common cancers. In the study...
Read More
April 04, 2018 - 6:47 am
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Fabian V. Filipp, University of California, Merced (THE CONVERSATION) Because of advances in drug design and precision medicine, researchers have been able to target certain molecules...
Read More
This photo provided by AstraZeneca shows a bottle of Lynparza. On Friday, Jan. 12, 2018, the Food and Drug Administration approved AstraZeneca PLC's Lynparza, the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene. (Courtesy of AstraZeneca via AP)
January 12, 2018 - 2:49 pm
U.S. regulators have approved the first drug aimed at women with advanced breast cancer caused by an inherited flawed gene. The Food and Drug Administration on Friday approved AstraZeneca PLC's Lynparza for patients with inherited BRCA gene mutations who have undergone chemotherapy. The drug has...
Read More
January 08, 2018 - 12:01 pm
GREENVILLE, S.C. (AP) — A year ago, Brittain Bass was just coming to grips with being told he had Hodgkin's lymphoma. "Twenty-three-year-olds don't get cancer," he told The Greenville News at the time. "You never think about it happening to you." But a tumor was indeed growing in his chest and it...
Read More
This photo provided by AstraZeneca shows the company's drug Calquence. On Tuesday, Oct. 31, 2017, the Food and Drug Administration approved Calquence, a new treatment for people with a rare and deadly form of non-Hodgkin lymphoma. (Peter Bostrom/AstraZeneca PLC via AP)
October 31, 2017 - 2:52 pm
U.S. regulators have approved a new treatment for people with a rare form of non-Hodgkin lymphoma. The Food and Drug Administration on Tuesday granted accelerated approval to AstraZeneca PLC's Calquence for people with mantle cell lymphoma after chemotherapy or other treatments fail. The British...
Read More
October 12, 2017 - 1:31 pm
ST. LOUIS (AP) — A giant bell on a billboard in St. Louis will ring every time a child completes chemotherapy at a local hospital. The St. Louis Post-Dispatch reports that the 12-foot-tall (3.6-meter-tall) metal bell was installed Wednesday on a billboard over Interstate 44. The billboard says: "...
Read More
FILE - In this Sept. 8, 2017 file photo provided by Sonya Nelson, Life Lynn DeKlyen lies in the Neonatal Intensive Care Unit of the University of Michigan Hospital in Ann Arbor, Mich. Sonya Nelson says her niece, Life Lynn DeKlyen, died Wednesday evening at University of Michigan Hospital in Ann Arbor. Her mother, Carrie DeKlyen who sacrificed the chance to prolong her life to give birth to Life Lynn, her sixth child, died Sept. 9, 2017. DeKlyen chose to forgo clinical trials and chemotherapy to treat her brain cancer, since it would have meant ending her pregnancy. (Nick DeKlyen/Courtesy of Sonya Nelson via AP File)
September 21, 2017 - 1:37 pm
DETROIT (AP) — A tiny preemie whose gravely ill mother had hoped to save her by shunning chemotherapy during pregnancy has died, a relative said Thursday. Sonya Nelson said her niece, Life Lynn DeKlyen, died Wednesday evening at the University of Michigan Hospital in Ann Arbor. Life's mother,...
Read More
August 15, 2017 - 3:14 pm
John Andretti has started another round of chemotherapy. The former NASCAR and IndyCar driver used Twitter on Monday to provide an update on his fight against colon cancer: "Same cocktail with an added twist. Only 3 months to go." The 54-year-old Andretti made his diagnosis public in early May and...
Read More
FILE - This Sept. 11, 2016 file photo shows Colorado Rockies starting pitcher Chad Bettis working against a San Diego Padres batter during the first inning of a baseball game in San Diego. Bettis will complete his comeback from chemotherapy for testicular cancer by starting the game in Denver against Atlanta on Monday, Aug. 14, 2017. (AP Photo/Ryan Kang, file)
August 14, 2017 - 7:47 pm
DENVER (AP) — The Colorado Rockies are thrilled to see Chad Bettis back on the mound after cancer treatment. The prospect of the right-hander helping them in a playoff push, that's a bonus. Bettis was set to start Monday night at Coors Field in his first major league game since being diagnosed with...
Read More

Pages